| Χρονικό πλαίσιο | Προβλεπόμενη τιμή | Το παρελθόν | Ιστορικός | Διορατικότητα |
|---|---|---|---|---|
| Αύριο | $2.88 ▲ +1.33% | Χθες | $2.82 ▼ -0.56% | Tomorrow's Cellectar Biosciences Inc. Common Stock (CLRB) setup is anchored to $2.84 and targets $2.88 (+1.33%). The near-term read is upside; watch $2.93 / $2.75 because daily realized volatility is about 6.84%. |
Tomorrow's Cellectar Biosciences Inc. Common Stock (CLRB) setup is anchored to $2.84 and targets $2.88 (+1.33%). The near-term read is upside; watch $2.93 / $2.75 because daily realized volatility is about 6.84%. | ||||
| Εβδομάδα | $2.96 ▲ +4.12% | Την περασμένη εβδομάδα | $2.79 ▼ -1.73% | The 7-day Cellectar Biosciences Inc. Common Stock model moves from $2.79 to $2.96 (+4.12%). It gives upside momentum context for this stock, so breaks around $2.93 / $2.75 matter more than a single tick. |
The 7-day Cellectar Biosciences Inc. Common Stock model moves from $2.79 to $2.96 (+4.12%). It gives upside momentum context for this stock, so breaks around $2.93 / $2.75 matter more than a single tick. | ||||
| Μήνας | $3.09 ▲ +8.79% | τον περασμένο μήνα | $2.74 ▼ -3.69% | The 1-month Cellectar Biosciences Inc. Common Stock target is $3.09 (+8.79%), compared with the live reference near $2.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Cellectar Biosciences Inc. Common Stock target is $3.09 (+8.79%), compared with the live reference near $2.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| έτος | $3.29 ▲ +15.77% | Πέρυσι | $2.65 ▼ -6.62% | The 1-year Cellectar Biosciences Inc. Common Stock scenario points to $3.29 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Cellectar Biosciences Inc. Common Stock scenario points to $3.29 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Χρόνια | $3.75 ▲ +32.14% | 5 Πριν από χρόνια | $2.46 ▼ -13.50% | The 5-year Cellectar Biosciences Inc. Common Stock view is $3.75 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Cellectar Biosciences Inc. Common Stock view is $3.75 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Δείκτης | Αξία | Σύνθημα |
|---|---|---|
| Price | $2.84 | Mid |
| Daily Change | -3.73% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 65% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $2.84 | Daily Change | -3.73% |
| Market Cap | $12.04M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.